A Delaware federal judge on Oct. 7 upheld Endo Pharmaceuticals Inc.'s patent for its opioid painkiller Opana ER, rejecting arguments by Amneal Pharmaceuticals and Teva Pharmaceuticals USA that the patent claim was invalid as obvious and that Teva had obtained permission to use its active ingredient.
- Oil Drilling Patent Infringement Case to Stay in Delaware
- In Case Over Services Denied Deaf Inmate, High Court Says Prisons Aren't 'Public Accommodations'
- Facebook Co-Founder Sued Over Startup Bankruptcy
- DuPont Thrown Back Into Overtime Class Action
- Reger Rizzo Partner Scheduled to Present Paralegal Course
- Morris James Attorney Named Co-Chair in ULI Philadelphia
- Anderson v. GRCR, LLC, DeFAX Case No. D67383 (D. Del. Sept. 29, 2016) Stark, J. (15 pages).
- Shahin v. City of Dover Bd. of Assessment Appeals, DeFAX Case No. D67381 (Del. Sept. 27, 2016) Holland, J. (7 pages).
- Jones v. Delaware Rapid Transit Corp., DeFAX Case No. D67377 (Del. Super. Oct. 13, 2016) LeGrow, J. (10 pages).
- TP Grp.-CI v. Vetecnik, DeFAX Case No. D67384 (D. Del. Oct. 6, 2016) Andrews, J. (6 pages).